NovaBay Pharmaceuticals has reported impressive growth in its eyecare business with first half sales hitting $4.8 million, and projections suggest it will reach $10 million for the year.
The company noted a significant increase in gross margin to 66%, indicating improved efficiency and profitability within its product revenue streams, bolstered by strategic digital marketing initiatives.
NovaBay experienced a remarkable 123% rise in Subscribe & Save customers for Avenova on Amazon, reflecting the effectiveness of their marketing efforts and a growing customer base.
Despite not pursuing international expansion independently, NovaBay is focusing on partnering strategically, especially as it targets the expansive U.S. dry eye market projected to surpass $4.8 billion by 2030.
Collection
[
|
...
]